Furthermore, because five complete treatments over fifteen days were lethal to the tumor-bearing mice receiving intravenous anti-PD-L1 antibody injections, we have hypothesized that the mice would only be able to tolerate up to three treatments without showing significant weight changes based upon the survival analysis. Here, CD274 is linked to neoplasm.